In CRC, LASP1 is reported to enhance tumor progression and metastatic potential through the activation of the mitogen‐activated protein kinase signaling pathway [42], Hippo signaling pathway [43], or through interaction with the CCT8 [44]. The gene discussed is CCT8; the disease is neoplasm.